Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-01

Clinical Trial Update: Recombinant Follicle-stimulating Hormone in Treatment for Infertility [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for recombinant follicle-stimulating hormone in the treatment of female infertility.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • recombinant follicle-stimulating hormone (recombinant follicle-stimulating hormone)

Snippet

Sponsor: Bharat Serums and Vaccines Limited | Conditions: Female Infertility | Phase 3 | Status: UNKNOWN